RG
TMCI icon

Redmile Group’s Treace Medical Concepts TMCI Stock Holding History

Redmile Group’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-323,765
Closed -$10.1M – 86
2021
Q2 		$10.1M Buy
+323,765
New +$10.3M 0.15% 74

Other funds holding TMCI

AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.89B AUM 151.53% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return

Redmile Group's TMCI Position: Q3 2021 in Review

Redmile Group sold out of Treace Medical Concepts (TMCI) in Q3 2021, closing a stake of 323,765 shares — an estimated $10.1M sold.

Redmile Group first reported a position in TMCI in Q2 2021 and held it in 1 quarter. The position peaked at $10.1M in Q2 2021. 62 funds tracked by Wall St. Rank hold TMCI as of Q3 2021.

  • Redmile Group reported no remaining Treace Medical Concepts position as of Q3 2021 after selling out during the quarter.
  • Redmile Group sold 323,765 Treace Medical Concepts shares in Q3 2021, an estimated $10.1M.
  • Redmile Group first reported a position in Treace Medical Concepts in Q2 2021 and held it in 1 quarter.
  • Redmile Group's Treace Medical Concepts position peaked at $10.1M in Q2 2021.
  • 62 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q3 2021.

Based on Redmile Group's 13F filing for Q3 2021, filed 15 Nov 2021.